Pharma got all its $$$$ back in these in less than two years
The most common user-reported experience: Temporary skin dryness in week 1 (resolves by week 2) Occasional injection site redness (standard for any subQ peptide) Some users report increased hair growth, including in unintended areas at higher doses At doses above 34 mg/day, some protocols note headaches, but this is well above standard dosing
Hormone replacement therapy (HRT) and glucagon-like peptide-1 (GLP-1) agonists have traditionally been considered separate therapeutic modalities
Size View COA 20mg View COA 40mg Research reference Overview Tirzepatide is a 39-amino-acid dual agonist that binds both the GIP and GLP-1 receptors from a single peptide backbone, with a C20 fatty-diacid moiety that extends its half-life in solution
Statistical analyses were performed using GraphPad Prism (version 9.0, GraphPad Software, San Diego, CA, USA)
If you are comfortable with a fully text-based medical interaction and do not require the reassurance of a video or in-person consultation, the Orderly Meds model works